ABACCEL Trademark

Scientific and technological services and research projects for the preparation of peptide and antibody libraries, and for the identification and characterisation of binding molecules, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects for the preparation, identification and characterisation of peptides or antibodies, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects for the preparation, identification and characterisation of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, or antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of natural, engineered and immunized libraries, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of antibody libraries, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to antibody development strategies, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to the optimization, maturation and humanization of antibody drug candidates, namely scientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to multi-factor antibody optimization, namely scientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to the optimization of antibody binding affinity, antibody stability, species cross-reactivity, specificity, developability, producibility, and human properties, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to human and nonhuman lead antibody technology, namely scientific research and analysis in the field of antibody research and antibody optimization